Skip to content

Research paper

Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children

Neurology
Q1
Apr 2011
Citations: 49
Influential: 5
Interventional (Human) Studies
89

Study answer

What this study found

Folic acid substantially reduced phenytoin-induced gingival overgrowth in children on phenytoin monotherapy. At 6 months, any gingival overgrowth occurred in 13/62 (21.0%) with folic acid versus 51/58 (87.9%) with control; absolute risk reduction was 67% (95% CI 53.8%-80.1%), relative risk reduction was 0.76, and p < 0.001. Severe gingival overgrowth (grade ≥2) was also lower with folic acid: 2/62 (3.23%) versus 8/58 (13.79%) (p = 0.036).

Study & population
Randomized trial in children with epilepsy aged 6-15 years receiving phenytoin monotherapy at a tertiary care teaching hospital.
Intervention
Folic acid 0.5 mg orally once daily for 6 months.
Key limitation
Single-center study in a tertiary hospital with a narrow pediatric epilepsy population on phenytoin monotherapy, which limits generalizability.
View sourceOpen PDF

Original abstract

Objective: Gingival overgrowth is an important adverse effect of phenytoin (PHT) therapy, occurring in about half of the patients. This study aimed to evaluate the effect of oral folic acid supplementation (0.5 mg/day) for the prevention of PHT-induc…